Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ALBUTEIN 25% VIAL

ALBUMIN (HUMAN)
$0.4951per ML

Strength

12.5 g/50mL

Manufacturer

GRIFOLS USA, LLC

NDC

68516521602

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

INTRAVENOUS

Last Updated

11/19/2014

Active Ingredients

ALBUMIN HUMAN

Approval Type

Biologic (BLA)

FDA Application

BLA102478

On Market Since

3/1/2022

Pharmacological Classes

Human Serum Albumin
Increased Intravascular Volume
Increased Oncotic Pressure
Osmotic Activity
Serum Albumin [Chemical/Ingredient]

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

N/A

Generic Alternatives

1 alternative • Same active ingredient

ALBURX (HUMAN) 25% VIAL
Brand
44206025110•CSL Behring AG
$0.4951

Related Drugs

Same classification

GOLYTELY SOLUTION
Brand
52268010001•Braintree Laboratories, Inc.
$0.0060
per ML
FLEET PEDIA-LAX ENEMA
Brand
00132020220•C.B. Fleet Company, Inc.
$0.0204
per ML
MIRALAX POWDER
Brand
11523723404•Bayer HealthCare LLC
$0.0330
per GM
MIRALAX POWDER
Brand
11523723403•Bayer HealthCare LLC
$0.0370
per GM
MIRALAX POWDER
Brand
11523723402•Bayer HealthCare LLC
$0.0427
per GM
KLOR-CON 10 MEQ TABLET
Brand
00245531601•Upsher-Smith Laboratories LLC
$0.1093
per EA
KLOR-CON 10 MEQ TABLET
Brand
00245531611•Upsher-Smith Laboratories LLC
$0.1093
per EA
KLOR-CON 10 MEQ TABLET
Brand
00245531615•Upsher-Smith Laboratories LLC
$0.1093
per EA
KLOR-CON 8 MEQ TABLET
Brand
00245531501•Upsher-Smith Laboratories LLC
$0.1232
per EA
KLOR-CON 8 MEQ TABLET
Brand
00245531511•Upsher-Smith Laboratories LLC
$0.1232
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy